Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascaline Berthet

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 6, 2010
Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristicsClaire Julian-Reynier, Anne-Déborah Bouhnik, Emanuelle Mouret-Fourme, et al.
BMC Genomics|September 30, 2024
Fine mapping of RNA isoform diversity using an innovative targeted long-read RNA sequencing protocol with novel dedicated bioinformatics pipelineCamille Aucouturier, Nicolas Soirat, Laurent Castéra, et al.
European Journal of Human Genetics : EJHG|February 20, 2014
Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genesLaurent Castéra, Sophie Krieger, Antoine Rousselin, et al.
European Journal of Medical Genetics|October 11, 2020
National recommendations of the French Genetics and Cancer Group - Unicancer on the modalities of multi-genes panel analyses in hereditary predispositions to tumors of the digestive tractMarion Dhooge, Stéphanie Baert-Desurmont, Carole Corsini, et al.
Bulletin Du Cancer|October 1, 2018
[The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition]Jessica Moretta, Pascaline Berthet, Valérie Bonadona, et al.
Plos One|September 26, 2015
Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2Sophie Blein, Laure Barjhoux, , et al.
European Journal of Medical Genetics|November 21, 2025
French recommendations on multi-gene panel testing in renal cell carcinomaSophie Giraud, Pascaline Berthet, Caroline Abadie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating GroupRichard M Brohet, David E Goldgar, Douglas F Easton, et al.
European Journal of Human Genetics : EJHG|December 20, 2017
Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancersLisa Golmard, Laurent Castéra, Sophie Krieger, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2025
Letrozole to prevent breast cancer in postmenopausal women with BRCA1/2 mutations (LIBER study)Pascal Pujol, Lise Roca, Alain Lortholary, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 6, 2010
Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristicsClaire Julian-Reynier, Anne-Déborah Bouhnik, Emanuelle Mouret-Fourme, et al.
BMC Genomics|September 30, 2024
Fine mapping of RNA isoform diversity using an innovative targeted long-read RNA sequencing protocol with novel dedicated bioinformatics pipelineCamille Aucouturier, Nicolas Soirat, Laurent Castéra, et al.
European Journal of Human Genetics : EJHG|February 20, 2014
Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genesLaurent Castéra, Sophie Krieger, Antoine Rousselin, et al.
European Journal of Medical Genetics|October 11, 2020
National recommendations of the French Genetics and Cancer Group - Unicancer on the modalities of multi-genes panel analyses in hereditary predispositions to tumors of the digestive tractMarion Dhooge, Stéphanie Baert-Desurmont, Carole Corsini, et al.
Bulletin Du Cancer|October 1, 2018
[The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition]Jessica Moretta, Pascaline Berthet, Valérie Bonadona, et al.
Plos One|September 26, 2015
Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2Sophie Blein, Laure Barjhoux, , et al.
European Journal of Medical Genetics|November 21, 2025
French recommendations on multi-gene panel testing in renal cell carcinomaSophie Giraud, Pascaline Berthet, Caroline Abadie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Oral contraceptives and breast cancer risk in the international BRCA1/2 carrier cohort study: a report from EMBRACE, GENEPSO, GEO-HEBON, and the IBCCS Collaborating GroupRichard M Brohet, David E Goldgar, Douglas F Easton, et al.
European Journal of Human Genetics : EJHG|December 20, 2017
Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancersLisa Golmard, Laurent Castéra, Sophie Krieger, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2025
Letrozole to prevent breast cancer in postmenopausal women with BRCA1/2 mutations (LIBER study)Pascal Pujol, Lise Roca, Alain Lortholary, et al.
Pageof 8